[1]
|
Fredriksson, I., Liljegren, G., Arnesson, L.G., Emdin, S.O., Palm-Sjövall, M., Fornander, T., Frisell, J. and Holmberg, L. (2001) Time Trends in the Results of Breast Conservation in 4694 Women. European Journal of Cancer, 37, 1537-1544. https://doi.org/10.1016/S0959-8049(01)00168-X
|
[2]
|
Garrido-Castro, A.C., Lin, N.U. and Polyak, K. (2019) Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treat-ment. Cancer Discovery, 9, 176-198.
https://doi.org/10.1158/2159-8290.CD-18-1177
|
[3]
|
Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immun-ity, Inflammation, and Cancer. Cell, 140, 883-899.
https://doi.org/10.1016/j.cell.2010.01.025
|
[4]
|
Xiong, S., Dong, L. and Cheng, L. (2021) Neutrophils in Cancer Carcinogenesis and Metastasis. Journal of Hematology & Oncology, 14, Article No. 173. https://doi.org/10.1186/s13045-021-01187-y
|
[5]
|
Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q. and Du, J. (2014) Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis. PLOS ONE, 9, e98259.
https://doi.org/10.1371/journal.pone.0098259
|
[6]
|
Nelson, M.A., Ngamcherdtrakul, W., Luoh, S.W. and Yantasee, W. (2021) Prognostic and Therapeutic Role of Tumor-Infiltrating Lymphocyte Subtypes in Breast Cancer. Cancer and Metastasis Reviews, 40, 519-536.
https://doi.org/10.1007/s10555-021-09968-0
|
[7]
|
Guthrie, G.J., Charles, K.A., Roxburgh, C.S., Horgan, P.G., McMillan, D.C. and Clarke, S.J. (2013) The Systemic Inflammation-Based Neutrophil-Lymphocyte Ratio: Experience in Patients with Cancer. Critical Reviews in Oncology/Hematology, 88, 218-230. https://doi.org/10.1016/j.critrevonc.2013.03.010
|
[8]
|
Singh, S., Singh, J., Ganguly, R., Chandra, S., Samadi, F.M. and Suhail, S. (2021) Diagnostic Efficacy of Neutrophil to Lymphocyte Ratio (NLR) in Oral Potentially Malignant Dis-orders and Oral Cancer. Indian Journal of Pathology and Microbiology, 64, 243-249. https://doi.org/10.4103/IJPM.IJPM_138_20
|
[9]
|
Polk, N., Budai, B., Hitre, E., Patócs, A. and Mersich, T. (2022) High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival after Metastasectomy of Patients with Liver-Only Metastasis of Rectal Cancer. Pathology and Oncology Re-search, 28, Article ID: 1610315.
https://doi.org/10.3389/pore.2022.1610315
|
[10]
|
Gong, Z., Xin, R., Li, L., Lv, L. and Wu, X. (2022) Plate-let-to-Lymphocyte Ratio Associated with the Clinicopathological Features and Prognostic Value of Breast Cancer: A Meta-Analysis. The International Journal of Biological Markers, 37, 339-348. https://doi.org/10.1177/03936155221118098
|
[11]
|
Chen, X., Chen, X., Yang, J., Li, Y., Fan, W. and Yang, Z. (2020) Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of Computer Assisted Tomography, 44, 275-283. https://doi.org/10.1097/RCT.0000000000000978
|
[12]
|
Fisher, C.S., Ma, C.X., Gillanders, W.E., Aft, R.L., Eber-lein, T.J., Gao, F. and Margenthaler, J.A. (2012) Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response. Annals of Surgical Oncology, 19, 253-258.
https://doi.org/10.1245/s10434-011-1877-y
|
[13]
|
Heng, D.Y., Xie, W., Regan, M.M., Warren, M.A., Golshayan, A.R., Sahi, C., Eigl, B.J., Ruether, J.D., Cheng, T., North, S., Venner, P., Knox, J.J., Chi, K.N., Kollmannsberger, C., McDermott, D.F., Oh, W.K., Atkins, M.B., Bukowski, R.M., Rini, B.I. and Choueiri, T.K. (2009) Prognostic Factors for Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Fac-tor-Targeted Agents: Results from a Large, Multicenter Study. Journal of Clinical Oncology, 27, 5794-5799. https://doi.org/10.1200/JCO.2008.21.4809
|
[14]
|
Ocana, A., Nieto-Jiménez, C., Pandiella, A. and Templeton, A.J. (2017) Neutrophils in Cancer: Prognostic Role and Therapeutic Strategies. Molecular Cancer, 16, Article No. 137. https://doi.org/10.1186/s12943-017-0707-7
|
[15]
|
Templeton, A.J., McNamara, M.G., Šeruga, B., Vera-Badillo, F.E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J.J., Tran, B., Tannock, I.F. and Amir, E. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124.
https://doi.org/10.1093/jnci/dju124
|
[16]
|
Grassadonia, A., Graziano, V., Iezzi, L., Vici, P., Barba, M., Pizzuti, L., Cicero, G., Krasniqi, E., Mazzotta, M., Marinelli, D., Amodio, A., Natoli, C. and Tinari, N. (2021) Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Set-ting. Cells, 10, 1685.
https://doi.org/10.20944/preprints202105.0144.v1
|
[17]
|
Chou, H.H., Kuo, W.L., Yu, C.C., Tsai, H.P., Shen, S.C., Chu, C.H., Yu, M.C., Lo, Y.F, Dabora, M.A., Chang, H.K., Lin, Y.C., Ueng, S.H. and Chen, S.C. (2019) Impact of Age on Pathological Complete Response and Locoregional Recurrence in Locally Advanced Breast Cancer after Neoad-juvant Chemotherapy. Biomedical Journal, 42, 66-74.
https://doi.org/10.1016/j.bj.2018.10.007
|
[18]
|
Keskin, S., Muslumanoglu, M., Saip, P., Karanlık, H., Guveli, M., Pehlivan, E., Aydoğan, F., Eralp, Y., Aydıner, Y., Yavuz, E., Ozmen, V., Igci, A. and Topuz, E. (2011) Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy. Oncology, 81, 30-38.
https://doi.org/10.1159/000330766
|
[19]
|
Chen, X., He, C., Han, D., Zhou, M., Wang, Q., Tian, J., Li, L., Xu, F., Zhou, E. and Yang, K. (2017) The Predictive Value of Ki-67 before Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Future Oncology, 13, 843-857. https://doi.org/10.2217/fon-2016-0420
|
[20]
|
Symmans, W.F., Peintinger, F., Hatzis, C., Rajan, R., Kuerer, H., Valero, V., Assad, L., Poniecka, A., Hennessy, B., Green, M., Buzdar, A.U., Singletary, S.E., Hortobagyi, G.N. and Pusztai, L. (2007) Measurement of Residual Breast Cancer Burden to Predict Survival after Neoadjuvant Chemotherapy. Journal of Clinical Oncology, 25, 4414-4422.
https://doi.org/10.1200/JCO.2007.10.6823
|
[21]
|
Hagenaars, S.C., de Groot, S., Cohen, D., Dekker, T.J.A., Charehbili, A., Meershoek-Klein Kranenbarg, E., Duijm-de Carpentier, M., Pijl, H., Putter, H., Tollenaar, R., Kroep, J.R. and Mesker, W.E. (2021) Tumor-Stroma Ratio Is Associated with Miller-Payne Score and Pathological Response to Ne-oadjuvant Chemotherapy in HER2-Negative Early Breast Cancer. International Journal of Cancer, 149, 1181-1188. https://doi.org/10.1002/ijc.33700
|